Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.

Source:http://linkedlifedata.com/resource/pubmed/id/8164027

Download in:

View as

Triples

General Info

PMID
8164027